[Skip to Content]
[Skip to Content Landing]
Evidence-Based Dermatology: Research Commentary
March 2009

Alitretinoin as a Potential Advance in the Management of Severe Chronic Hand Eczema

Author Affiliations
 

MICHAELBIGBYMD

 

DAMIANOABENIMD, MPHROSAMARIACORONADSc, MDURBÀGONZÁLEZMD, PhDABRAR AQURESHIMD, MPHHYWELWILLIAMSMSc, PhD, FRCP

Arch Dermatol. 2009;145(3):314-315. doi:10.1001/archdermatol.2008.608

Commentary on: Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial

Ruzicka T, Lynde CW, Jemec GB, et al

Br J Dermatol. 2008;158(4):808-817

Question: Is oral alitretinoin, at a dose of 10 or 30 mg once daily, an effective and safe treatment for severe chronic hand eczema (CHE) refractory to topical corticosteroids?

×